Clinical utilization of olaparib, a PARP inhibitor, in BRCA1-mutant metastatic acral melanoma.

ABSTRACT:

SUBMITTER: Jiang R 

PROVIDER: S-EPMC10363622 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature